Pharmaceutical

Allink Biotherapeutics secures funding to advance ADC p...

Allink Biotherapeutics has completed a $42m Series A financing round to expedite...

Formosa and Medvisis agree on post-operative eye pain t...

Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 f...

Trump 2.0 spells global change in pharmaceutical regula...

Trump's controversial administration nominees signal global ramifications for dr...

Advanz Pharma’s liver disease drug pulled from European...

This latest update comes after Advanz secured a suspension of the European Commi...

NHS rolls out monoclonal antibody treatment for rare bo...

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres a...

Eton acquires US rights to neonatal diabetes treatment ...

Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitu...

Roche’s tiragolumab flops in another Phase III lung can...

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 addin...

Gilead adds investigational HIV vaccine to its portfoli...

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration a...

Roche to acquire Poseida Therapeutics for $1.5bn

Roche has signed an agreement for the acquisition of Poseida Therapeutics in a d...

Shorla Oncology’s IMKELDI approved by FDA for leukaemia...

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI fo...

Pharmaceutical Technology Excellence Awards 2024: PCI P...

PCI Pharma Services is a winner in the Innovation and Business Expansion categor...

Adcendo raises $135m as ADC funding frenzy continues 

This latest raise is intended to accelerate the development of the biotech’s fou...

Sustainability in biopharma: Collaboration and technolo...

The biopharmaceutical industry is being called to take its sustainability effort...

Arrowhead and Sarepta link for rare genetic disease tre...

Arrowhead has entered a worldwide licensing and partnership agreement with Sarep...

FDA approves BridgeBio’s Attruby for ATTR-CM treatment

The US FDA has approved BridgeBio Pharma’s Attruby (acoramidis) for treating adu...

Amneal files again for FDA approval of first dihydroerg...

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe a...